Ivanova, Elizaveta,
Asadullina, Dilara,
Gilyazova, Gulshat,
Rakhimov, Radmir,
Izmailov, Adel,
Pavlov, Valentin,
Khusnutdinova, Elza,
Gilyazova, Irina (2023) Immunotherapy with
immune checkpoint inhibitors (ICIs) has shown high efficiency in
clear cell
improvement on the fourth visit. The work of the periodontal
immune system is partly determined
Gilyazova, Irina,
Asadullina, Dilara,
Kagirova, Evelina,
Sikka, Ruhi,
Mustafin, Artur,
Ivanova, Elizaveta,
Bakhtiyarova, Ksenia,
Gilyazova, Gulshat,
Gupta, Saurabh,
Khusnutdinova, Elza,
Gupta, Himanshu,
Pavlov, Valentin (2023) inflammatory processes, haemopoiesis, allergic responses, and other key aspects of the innate
immune system
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) related toxicity.
Immune-related adverse events (irAEs) are a major cause of
immune checkpoint inhibitors
МАРКЕРЫ ИММУНОКОМПРОМЕТАЦИИ ПРИ ВОЗДЕЙСТВИИ КСЕНОБИОТИКОВПисарев, В.М.,
Тутельян, А.В.,
Хасанова, Г.М.,
Pisarev, V.M.,
Tutelyan, A.V.,
Khasanova, G.M. (2018) is carried out. Biomarkers of immunocompromentation of congenital and adaptive
immunity are
proposed.
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC,
immune checkpoint